Overexpression of Nucleolin and Associated Genes in Prostate Cancer.
biomarker
nucleolin
prostate cancer
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
19 Apr 2022
19 Apr 2022
Historique:
received:
14
03
2022
revised:
04
04
2022
accepted:
07
04
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
18
5
2022
Statut:
epublish
Résumé
Prostate cancer (PCa) is the second most frequent cancer and the fifth leading cause of cancer death in men worldwide. If local PCa presents a favorable prognosis, available treatments for advanced PCa display limiting benefits due to therapeutic resistances. Nucleolin (NCL) is a ubiquitous protein involved in numerous cell processes, such as ribosome biogenesis, cell cycles, or angiogenesis. NCL is overexpressed in several tumor types in which it has been proposed as a diagnostic and prognostic biomarker. In PCa, NCL has mainly been studied as a target for new therapeutic agents. Nevertheless, little data are available concerning its expression in patient tissues. Here, we investigated the expression of NCL using a new cohort from Mondor Hospital and data from published cohorts. Results were then compared with NCL expression using
Identifiants
pubmed: 35562881
pii: ijms23094491
doi: 10.3390/ijms23094491
pmc: PMC9101690
pii:
doi:
Substances chimiques
Biomarkers
0
Phosphoproteins
0
RNA-Binding Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Eur Urol Focus. 2016 Dec;2(5):506-513
pubmed: 28723516
Urology. 2010 Oct;76(4):1017.e1-6
pubmed: 20708221
Cancer Res. 2016 Dec 15;76(24):7181-7193
pubmed: 27754848
Prostate. 2017 Jan;77(1):10-21
pubmed: 27550065
FEBS Lett. 2014 May 21;588(10):1921-9
pubmed: 24713430
J Cell Biol. 2003 Nov 24;163(4):871-8
pubmed: 14638862
Cancer Manag Res. 2021 Feb 25;13:1955-1965
pubmed: 33658856
Lancet Oncol. 2018 Oct;19(10):1404-1416
pubmed: 30213449
N Engl J Med. 2013 Jan 10;368(2):138-48
pubmed: 23228172
Cancer Res. 2011 May 1;71(9):3296-305
pubmed: 21415166
J Cell Biochem. 2012 Feb;113(2):571-9
pubmed: 21938743
Tumour Biol. 2016 Sep;37(9):12843-12854
pubmed: 27449037
Mol Pharm. 2018 May 7;15(5):1972-1978
pubmed: 29669200
Anticancer Res. 2011 Oct;31(10):3129-35
pubmed: 21965718
Mol Cancer Ther. 2006 Jul;5(7):1790-9
pubmed: 16891465
Neuro Oncol. 2008 Oct;10(5):675-89
pubmed: 18701711
Cancers (Basel). 2021 Jul 28;13(15):
pubmed: 34359692
Biochimie. 2015 Jun;113:78-85
pubmed: 25866190
PLoS One. 2008 Jun 18;3(6):e2518
pubmed: 18560571
Anticancer Res. 2020 Apr;40(4):1973-1979
pubmed: 32234886
Proc SPIE Int Soc Opt Eng. 2016 Feb 13;9708:
pubmed: 28529403
N Engl J Med. 2021 Sep 16;385(12):1091-1103
pubmed: 34161051
Exp Mol Pathol. 2009 Jun;86(3):151-64
pubmed: 19454272
Int J Biol Macromol. 2020 Jul 15;155:1420-1431
pubmed: 31734366
Adv Protein Chem Struct Biol. 2018;111:133-164
pubmed: 29459030
PLoS One. 2013 Sep 24;8(9):e75269
pubmed: 24086490
Nat Biotechnol. 2020 Jun;38(6):675-678
pubmed: 32444850
Cancer Res. 2010 Nov 1;70(21):8617-29
pubmed: 20861190
APMIS. 2013 Oct;121(10):919-25
pubmed: 23763304
Hum Pathol. 2009 Jul;40(7):924-33
pubmed: 19368959
Blood. 2006 May 1;107(9):3564-71
pubmed: 16403913
PLoS One. 2008 Jun 04;3(6):e2310
pubmed: 18523588
FEBS J. 2005 Sep;272(18):4646-59
pubmed: 16156786
Mol Cell Biol. 2002 Oct;22(19):6788-96
pubmed: 12215536
Lancet. 2010 Oct 2;376(9747):1147-54
pubmed: 20888992
N Engl J Med. 2020 Sep 10;383(11):1040-1049
pubmed: 32905676
Angiogenesis. 2009;12(1):91-100
pubmed: 19225898
Eur Urol. 2013 Feb;63(2):189-97
pubmed: 23000088
Clin Cancer Res. 2010 Jul 15;16(14):3734-42
pubmed: 20628027
Clin Genitourin Cancer. 2017 Jun;15(3):e477-e481
pubmed: 28153390
Cancers (Basel). 2020 Jul 10;12(7):
pubmed: 32664322
N Engl J Med. 2004 Oct 7;351(15):1502-12
pubmed: 15470213
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
Oncotarget. 2016 Oct 25;7(43):69397-69411
pubmed: 26993766
Life Sci Alliance. 2019 Nov 15;2(6):
pubmed: 31732695
BMC Cancer. 2011 May 30;11:212
pubmed: 21624116
Blood. 2013 Jun 6;121(23):4729-39
pubmed: 23599269
Eur Urol Focus. 2017 Oct;3(4-5):487-497
pubmed: 28753804
N Engl J Med. 2012 Sep 27;367(13):1187-97
pubmed: 22894553
Mol Pharm. 2018 Jan 2;15(1):314-325
pubmed: 29250957
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Cell. 1989 Feb 10;56(3):379-90
pubmed: 2914325
Cancer Res. 2011 Mar 15;71(6):2140-51
pubmed: 21257709
Mol Oncol. 2015 Aug;9(7):1392-405
pubmed: 25911416
Diagn Pathol. 2014 Sep 18;9:175
pubmed: 25230759
Nucleic Acids Res. 2017 Aug 21;45(14):8508-8523
pubmed: 28591869
Mol Cell Biochem. 2014 Jan;386(1-2):189-98
pubmed: 24104455
J Exp Med. 2002 Oct 21;196(8):1067-78
pubmed: 12391018
J Exp Med. 2013 May 6;210(5):951-68
pubmed: 23610125
PLoS One. 2016 Jul 07;11(7):e0157670
pubmed: 27388901
Nat Commun. 2018 Oct 5;9(1):4113
pubmed: 30291252
Prostate. 1994;24(2):101-6
pubmed: 8309845
BMC Cancer. 2006 Jul 25;6:197
pubmed: 16869958